| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 19.18▼ | 19.14▼ | 19.14▼ | 19.96▼ | 22.00▼ |
| MA10 | 19.29▼ | 19.37▼ | 19.50▼ | 20.16▼ | 22.36▼ |
| MA20 | 19.40▼ | 19.84▼ | 20.00▼ | 21.93▼ | 23.94▼ |
| MA50 | 19.95▼ | 20.19▼ | 20.63▼ | 22.59▼ | 29.41▼ |
| MA100 | 20.17▼ | 21.71▼ | 22.32▼ | 24.30▼ | 28.40▼ |
| MA200 | 21.53▼ | 22.68▼ | 22.74▼ | 28.80▼ | 24.16▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.018▼ | -0.079▼ | -0.088▼ | -0.258▼ | -0.180▼ |
| RSI | 37.399▼ | 35.907▼ | 35.429▼ | 28.197▼ | 30.097▼ |
| STOCH | 45.227 | 10.602▼ | 5.989▼ | 19.637▼ | 27.653 |
| WILL %R | -62.838 | -80.565▼ | -86.181▼ | -94.522▼ | -96.361▼ |
| CCI | -83.364 | -85.354 | -87.549 | -112.071▼ | -218.408▼ |
|
Thursday, September 24, 2026 12:00 AM
Mesoblast’s Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA-approved ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/09/26 | 18.88 | 19.115 | 18.84 | 19.115 | 35,863 |
| 24/09/26 | 20.17 | 20.31 | 19.26 | 19.39 | 44,814 |
| 23/09/26 | 20.58 | 20.67 | 19.9601 | 20.17 | 19,027 |
| 22/09/26 | 20.39 | 20.8999 | 20.39 | 20.73 | 33,053 |
| 21/09/26 | 20.30 | 20.90 | 20.11 | 20.40 | 40,281 |
| 18/09/26 | 20.27 | 20.5854 | 19.70 | 20.30 | 40,711 |
| 17/09/26 | 19.95 | 20.39 | 19.32 | 19.91 | 110,177 |
| 16/09/26 | 20.69 | 21.13 | 19.75 | 19.86 | 37,300 |
| 15/09/26 | 21.10 | 21.2112 | 20.54 | 20.54 | 25,952 |
| 14/09/26 | 22.57 | 23.08 | 20.63 | 21.17 | 53,947 |
|
|
||||
|
|
||||
|
|